KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Merck (MRK) EBT (2016 - 2025)

Merck (MRK) has disclosed EBT for 17 consecutive years, with $3.4 billion as the latest value for Q4 2025.

  • Quarterly EBT fell 17.99% to $3.4 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $21.1 billion through Dec 2025, up 5.67% year-over-year, with the annual reading at $21.1 billion for FY2025, 5.67% up from the prior year.
  • EBT for Q4 2025 was $3.4 billion at Merck, down from $6.7 billion in the prior quarter.
  • The five-year high for EBT was $6.7 billion in Q3 2025, with the low at -$5.3 billion in Q2 2023.
  • Average EBT over 5 years is $3.7 billion, with a median of $4.1 billion recorded in 2024.
  • The sharpest move saw EBT plummeted 218.9% in 2023, then surged 303.81% in 2024.
  • Over 5 years, EBT stood at $3.9 billion in 2021, then dropped by 10.13% to $3.5 billion in 2022, then crashed by 158.24% to -$2.0 billion in 2023, then soared by 303.81% to $4.2 billion in 2024, then decreased by 17.99% to $3.4 billion in 2025.
  • According to Business Quant data, EBT over the past three periods came in at $3.4 billion, $6.7 billion, and $5.0 billion for Q4 2025, Q3 2025, and Q2 2025 respectively.